Results 191 to 200 of about 37,455 (293)

Observing IUDs 'in-situ' [PDF]

, 2017
Adriaens, Mieke, Dowsett, Mark, Grayburn, Rosie, Sabbe, Pieter-Jan   +3 more
core   +1 more source

An open‐label, single‐arm, dose‐escalating concentration–QT study to investigate the cardiac effects and safety of paroxetine in healthy adults

British Journal of Clinical Pharmacology, Volume 92, Issue 5, Page 1385-1396, May 2026.
Abstract Aims Paroxetine is a selective serotonin reuptake inhibitor (SSRI), approved for treatment of major depressive disorder and anxiety disorders. Some SSRIs are known to prolong the QT interval; however, clinical evidence to establish a lack of association between paroxetine and corrected QT interval (QTc) prolongation is limited. Therefore, this
Sven C. van Dijkman, Mathieu Félices, Bhaskar Pandurangavittal, Sanman Ghorpade, Caroline Easterbrook, Marcin Zabielski, Oscar Della Pasqua   +6 more
wiley   +1 more source

Efficacy of Fertility‐Sparing Treatment With Progestin Is Associated With Different Molecular Classification in Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Cancer Medicine, Volume 15, Issue 5, May 2026.
Molecular profiles and outcomes of CR rate in 74 cases. ABSTRACT Objective To investigate the impact of various molecular characteristics on the outcomes of fertility‐preserving therapy in patients with endometrial cancer (EC) and atypical endometrial hyperplasia (AEH).
Xue‐Qian Qian, Hao‐Hui Fu, Xiao‐Yun Wan, Dong‐Xiao Hu, Yuan‐Ming Shen   +4 more
wiley   +1 more source

Subdermal implants vs. levonorgestrel intrauterine devices outcomes in reproductive-aged women: a systematic review and meta-analysis. [PDF]

Arch Gynecol Obstet
Oliveira JA, Neves GL, Pinhati MES, de Oliveira FR, Filho ALDS.   +4 more
europepmc   +1 more source

Candida glabrata Isolated From Tubo‐Ovarian Abscess Cultures in Two Immunocompetent Patients

Clinical Case Reports, Volume 14, Issue 5, May 2026.
Persistent 7.3 × 5.8 cm TOA unresponsive to 4 weeks of antibiotic treatment and percutaneous drainage, growing Candida glabrata on cultures. ABSTRACT In this clinical case report, we present two immunocompetent patients with tubo‐ovarian abscesses (TOAs) that were positive for Candida glabrata.
Marlee Hirsch, Rosalie DePaola, Jordan Eisenberg, Amir Shay, Tyler M. Moore, Adi Katz, Richard A. Stein   +6 more
wiley   +1 more source

MCV/Q, Medical College of Virginia Quarterly, Vol. 16 No. 1 [PDF]

, 1980

core   +1 more source

Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies

Clinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1179-1194, May 2026.
Maternal health remains a critical global concern, particularly in underserved populations and in low‐ and middle‐income countries where access to safe and effective therapeutics is limited. Despite the use of medications by most women during pregnancy, the exclusion of pregnant and lactating women from clinical trials has resulted in significant data ...
Rachel K. Scott, Sharon Nachman, Ethel D. Weld, Rachel Daley, Shakir Atoyebi, Robert Bies, Catriona Waitt, Adeniyi Olagunju   +7 more
wiley   +1 more source

Clinical Evaluation of Li Brush Endometrial Samplers for Diagnosing Endometrial Lesions in Women With Intrauterine Devices. [PDF]

Front Med (Lausanne), 2020
Han L, Ma S, Zhao L, Liu Y, Wang Y, Feng X, Zhang K, Wang L, Wang L, Yin P, Liang D, Hou H, Shi G, Li Q.   +13 more
europepmc   +1 more source

Physical agents' level in women with primary dysmenorrhea: A cross‐sectional observational study

International Journal of Gynecology &Obstetrics, Volume 173, Issue 2, Page 721-730, May 2026.
Abstract Objective Primary dysmenorrhea (PD), menstrual pain in the absence of pathology, is the main reason for gynecological consultation in young women. Physical agents, used in physiotherapy for therapeutic purposes, can be self‐used by women with primary dysmenorrhea.
Zeltia Naia, Olalla Bello
wiley   +1 more source

An in-vivo study of the safety of copper-containing intrauterine devices in 3.0 Tesla magnetic resonance imaging. [PDF]

Abdom Radiol (NY)
Moy J, Landon M, Vigilante J, Lehmann B, DeChambeau A, Rohlfing F, Marks R.   +6 more
europepmc   +1 more source